Daniel LeSueur - Jan 6, 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Operating Officer
Signature: /s/ Benjamin Landry, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Jan 6, 2025
Transactions value $: -$39,134
Form type: 4
Date filed: 1/10/2025, 04:18 PM
Previous filing: Dec 6, 2024
Next filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Sale	-$39.1K	-5.21K	-5.4%	$7.51	91.3K	Jan 6, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 7, 2024 in accordance with Rule 10b5-1.